Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sinus headache: a clinical conundrum.

Roger K Cady1, Curtis P Schreiber

  • 1Headache Care Center, 1230 East Kingsley Street, Springfield, MO 65721, USA. rcady@primarycarenet.org

Otolaryngologic Clinics of North America
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P-tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2025
Same author

Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers.

Drugs & aging·2025
Same author

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant - post hoc results from an open label safety study (BHV3000-201).

The journal of headache and pain·2022
Same author

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial.

BMC neurology·2021
Same author

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide.

The Journal of pharmacology and experimental therapeutics·2019
Same author

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.

The journal of headache and pain·2017
Same journal

Obesity and Obstructive Sleep Apnea: Impact on Medical and Surgical Management.

Otolaryngologic clinics of North America·2026
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
See all related articles

Most self-diagnosed sinus headaches are actually migraines, responding to migraine treatments. True sinus headaches from nasal conditions can occur but often overlap with migraine symptoms.

Area of Science:

  • Neurology
  • Otolaryngology
  • Allergy and Immunology

Background:

  • Sinus disease is widely perceived as a common cause of headaches.
  • Limited scientific evidence supports sinuses as a frequent cause of disabling headaches.
  • Migraine can manifest with facial pain and nasal symptoms, mimicking sinus issues.

Purpose of the Study:

  • To investigate the diagnostic accuracy of self-diagnosed or physician-diagnosed sinus headaches.
  • To determine the prevalence of migraine criteria in patients presenting with sinus headache.
  • To evaluate treatment response in patients with presumed sinus headache.

Main Methods:

  • Clinical studies involving participants with self-diagnosed or physician-diagnosed sinus headache.
  • Assessment of participants against International Headache Society (IHS) migraine criteria.

Related Experiment Videos

  • Evaluation of response to triptan interventions, a common migraine treatment.

    • Main Results:

    • Nearly 90% of participants with sinus headache met IHS migraine criteria.
    • Patients with sinus headache showed a treatment response to triptans similar to migraine patients.
    • Nasal pathologies can cause headaches, but symptom overlap with migraine is significant.

    Conclusions:

    • The majority of individuals seeking care for sinus headache are likely experiencing migraine.
    • Migraine should be considered in the differential diagnosis of patients with facial pain and nasal symptoms.
    • Further research is needed to differentiate headaches caused by rhinosinusitis from migraine.